Percutaneous coronary intervention in the elderly patient

Journal of Invasive Cardiology

Volumn 18, Issue 6, 2006, Pages 286-295

  Klein, Lloyd W ^a,b,c  

^a Gottlieb Memorial Hospital   (United States)

^b RUSH MEDICAL COLLEGE   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOT LYSIS; CARDIOGENIC SHOCK; CARDIOVASCULAR RISK; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; ELDERLY CARE; HEART INFARCTION; HUMAN; INTERMETHOD COMPARISON; PERCUTANEOUS CORONARY INTERVENTION; REVIEW; RISK ASSESSMENT; ST SEGMENT ELEVATION; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS; AGED; CORONARY ARTERY ATHEROSCLEROSIS; MORTALITY; RISK FACTOR; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERIOSCLEROSIS; HUMANS; RISK FACTORS; ANGINA, UNSTABLE; SHOCK, CARDIOGENIC;

EID: 33747137008     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Review

References (78)

1. Lee PY, Alexander KP, Hammill BG, et al. Representation of elderly persons and women in published randomized trials of acute coronary syndromes. JAMA 2001;286:708-713.
2. Gregoratos G. Clinical manifestations of acute myocardial infarction in older patients. Am J Geriatr Cardiol 2001;10:345-347.
3. Rathore SS, Mehta RH, Wang Y, et al. Effects of age on the quality of care provided to older patients with acute myocardial infarction. Am J Med 2003;114:307-315.
4. Sheifer S, Rathore S, Gersh B, et al. Time to presentation with acute myocardial infarction in the elderly: Associations with race, sex, and socioeconomic characteristics. Circulation 2000;102:1651-1656.
5. Wennberg DE, Makenka DJ, Sengupta A, et al. Percutaneous transluminal coronary angiography in the elderly: Epidemiology, clinical risk factors and inhospital outcomes. The Northern New England Cardiovascular Disease Study Group. Am Heart J 1999;137:639-645.
6. Shaw R, Anderson H, Brindis R, et al. Development of a risk adjustment mortality model using the American College of Cardiology- National Cardiovascular Data Registry (ACC-NCDR) experience: 1998-2000. J Am Coll Cardiol 2002;39:1104-1112.
7. Hirshfield JW, Schwartz RS, Jugo R, et al. for the M-Heart Investigators. A multivariate statistical model to relate lesion and procedure variables to restenosis. J Am Coll Cardiol 1991;18:647-656.
8. Batchelor WB, Anstrom KJ, Muhlbaier LH, et al. for the NCN. Contemporary outcome trends in the elderly undergoing percutaneous coronary interventions: Results in 7,472 octogenarian. J Am Coll Cardiol 2000;36:723-730.
9. Vijaykumar M, Lemos PA, Haze A, et al. Effectiveness of sirolimus-eluting stent implantation for the treatment of coronary artery disease in octogenarian. Am J Cardiol 2004;94:909-913.
10. Taddei CF, Weintraub WS, Douglas JS, et al. Influence of age on outcome after percutaneous transluminal coronary angioplasty. Am J Cardiol 1999;84:245-251.
11. Peterson ED, Jullis JG, Bebchuk JD, et al. Changes in mortality after myocardial revascularization in the elderly. The National Medicare experience. Ann Intern Med 1994;121:919-927.
12. Hannan EL, Arani DT, Johnson LW, et al. Percutaneous transluminal coronary angioplasty in New York State. Risk factors and outcomes. JAMA 1992;268:3092-3097.
13. Laskey WK, Kimmel S, Krone RJ. Contemporary trends in coronary intervention: A report from the Registry of the Society for Cardiac Angiography and Interventions. Catheter Cardiovasc Interv 2000;49:19-22.
14. Thompson RC, Holmes DR, Grill DE. Changing outcome of angioplasty in the elderly. J Am Coll Cardiol 1996;27:8-24.
15. Rich JJ, Crispino CM, Saporito JJ, et al. Percutaneous transluminal coronary angioplasty in patients 80 years of age and older. Am J Cardiol 1990;65:675-676.
16. Kelsey SF, Miller DP, Holubkov R, et al. Results of percutaneous transluminal coronary angioplasty in patients ≥ 65 years of age (from the 1985 to 1986 National Heart, Lung and Blood Institute's coronary angioplasty registry). Am J Cardiol 1990;66:1033-1038.
17. MacDonald P, Johnstone D, Rockwood K. Coronary artery bypass surgery for elderly patients: Is our practice based on evidence or faith? Can Med Assoc J 2000;162:1005-1006.
18. Mehta RH, Rathore SS, Radford MJ, et al. Acute myocardial infarction in the elderly: Differences by age. J Am Coll Cardiol 2001;38:736-741.
19. Guyon P, Urban P, Lotanr C, et al. The impact of sirolimus-eluting stent implantation in the elderly: A report from the e-Cypher Registry (Abstr). Circulation 2004;110:II-3009.
20. Tu JU, Pashos CL, Naylor CD, et al. Use of cardiac procedures and outcomes in elderly patients with myocardial infarction in the United States and Canada. N Engl J Med 1997;336:1500-1505.
21. Graham MM, Ghali WA, Faris PO, et al. Survival after coronary revascularization in the elderly. Circulation 2002;105:2378-2383.
22. Seto TB, Taira DA, Berezin R, et al. Percutaneous coronary revascularization in elderly patients: Impact on functional status and quality of life. Ann Intern Med 2000;132:955-958.
23. The BARI Investigators. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. N Engl J Med 1996;335:217-225.
24. Windecker S, Remondino A, Eberli FR, et al. Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization. N Engl J Med 2005;353:653-662.
25. Lincoff AM, Bittl JA, Harrington RA, et al. Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein blockade during percutaneous coronary intervention. JAMA 2003;289:853-863.
26. The ESPRIT Investigators. The ESPRIT Study: A randomized, placebo-controlled trial of a novel dosing regimen of eptifibatide in planned coronary stent implantation. Lancet 2000;356:2037-2044.
27. Ferrari AU, Radaelli A, Centala M. Aging and the cardiovascular system. J Appl Physiol 2003;95:2591-2597.
28. Lansky AJ, Hochman JS, Ward PA, et al. Percutaneous coronary intervention and adjunctive pharmacotherapy in women: A statement for healthcare professionals from the American Heart Association. Circulation 2005;111:940-953.
29. Williams MA, Fleg JL, Ades PA, et al. Secondary prevention of heart disease in the elderly (with emphasis on patients > 75 years of age). Circulation 2002;105:1735-1743.
30. Halon DA, Adawi S, Dobrecky-Mery I, Lewis BS. Importance of increasing age on the presentation and outcome of acute coronary syndromes in elderly patients. J Am Coll Cardiol 2004;43:346-352.
31. Mehta RH, Sadiq I, Goldberg RJ, et al. Effectiveness of primary percutaneous coronary intervention compared with that of thrombolytic therapy in elderly patients with acute myocardial infarction. Am Heart J 2004;147:253-259.
32. Klein LW, Block P, Brindis R, et al. Percutaneous coronary interventions in octogenarian in the American College of Cardiology - National Cardiovascular Data Registry: Development of a nomogram predictive of in-hospital mortality. J Am Coll Cardiol 2002;40:349-402.
33. De Gregorio J, Kobayashi Y, Albiero R, et al. Coronary artery stenting in the elderly: Short-term outcome and long-term angiographic and clinical follow-up. J Am Coll Cardiol 1998;32:577-583.
34. De Geare V, Stone G, Grines L, et al. Angiographic and clinical characteristics associated with increased in-hospital mortality in elderly patients with acute myocardial infarction undergoing percutaneous intervention (A pooled analysis of the primary angioplasty in myocardial infarction trials). Am J Cardiol 2000;86:30-34.
35. Alexander K, Anstrom K, Muhlbaier L, et al. Outcomes of cardiac surgery in patients greater than or equal to 80 years old: Results from National Cardiovascular Network. J Am Coll Cardiol 2000;35:731-738.
36. Eckart RE, Shry EA, Simpson DF, Stajduhar KC. Percutaneous coronary intervention in the elderly: Procedural success and one year outcome. Am J Geriatr Cardiol 2003;12:366-368.
37. Voudris VA, Skoulargis JJ, Malakos JS, et al. Long-term clinical outcome of coronary artery stenting in elderly patients. Cor Artery Dis 2002;13:323-329.
38. Dynina O, Vakile BA, Slater JN, et al. In hospital outcomes of contemporary percutaneous coronary interventions in the very elderly. Catheter Cardiovasc Interv 2003;58:352-357.
39. Clark MA, Bakhai A, Lacey MT, et al. Clinical and economic outcomes of percutaneous coronary intervention in the elderly. Circulation 2004;110:259-264.
40. Aronow WS. Select MI. Prevalence and prognosis in older patients diagnosed by routine electrocardiograms. Geriatrics 2003;58:24-26, 36-40.
41. Rich MW. Treatment of myocardial infarction. Ger Cardiol 2001;10:328-336.
42. Gurwitz JH, Col WF, Avorn J. The exclusion of the elderly and women from clinical trials in acute myocardial infarction. JAMA 1992;268:1617-1422.
43. Lee KL, Woodlief LH, Topol EJ, et al. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Circulation 1995;91:1659-1668.
44. Van de Werf F, Topol EJ, Lee KL, et al for the GUSTO Investigators. Variations in patient management and outcomes for acute myocardial infarction in the United States and other countries. Results from the GUSTO trial. JAMA 1995;273:1586-1591.
45. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of mortality and major morbidity results from all randomized trials of more than 1000 patients. Lancet 1994;343:311-322.
46. Thiemann DR. Primary angioplasty for elderly patients with myocardial infarction: Theory, practice and possibilities. J Am Coll Cardiol 2002;39:1729-1732.
47. Thiemann DR, Coresh J, Schulman SP, et al. Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 years. Circulation 2002;101:2239-2246.
48. Silber S, Albertsson P, Aviles FF, et al. Guidelines for percutaneous coronary interventions: The task force for percutaneous coronary interventions of the European society of cardiology. Eur Heart J 2005;26:804-847.
49. Mehta RH, Granger CB, Alexander KP, et al. Reperfusion strategies for acute myocardial infarction in the elderly: Benefits and risks. J Am Coll Cardiol 2005;45:471-478.
50. The GUSTO V Investigation. Reperfusion therapy for acute myocardial information with fibrinolytic toe therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition. Lancet 2001;357:1905-1914.
51. Gersh BJ, Stone GW, White HD, Holmes DR Jr. Pharmacological facilitation of primary percutaneous intervention for acute myocardial infarction. JAMA 2005;293:979-986.
52. Ellis SG, Armstrong B, Betrim A, et al. Facilitated percutaneous coronary intervention versus primary percutaneous coronary intervention: Design and rationale of the FINESSE trial. Am Heart J 2004;147:E162.
53. Zahn R, Schiele R, Schneider S, et al. Primary angioplasty verses intravenous thrombolysis in acute myocardial infarction: Can we define subgroups of patients benefiting most from primary angioplasty? Results from the pooled data of the Maximal Infarction Registry. J Am Coll Cardiol 2001;37:1827-1835.
54. Berger AK, Radford MJ, Wang Y, Krumholz HM. Thrombolytic therapy in older patients. J Am Coll Cardiol 2000;36:366-374.
55. Berger AK, Radford MJ, Krumholz HM. Factors associated with delay in reperfusion therapy in elderly patients with acute myocardial infarction: Analysis of the cooperative cardiovascular project. Am Heart J 2000;139:985-992.
56. Soumerai SB, McLaughlin TJ, Ross-Degnan D, et al. Effectiveness of thrombolytic therapy for acute myocardial infarction in the elderly: Cause for concern in the old-old. Arch Intern Med 2002;162:561-568.
57. GUSTO IIb Angioplasty Substudy Investigations. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activation for acute myocardial infarction. N Engl J Med 1997;336:1621-1628.
58. Klein LW, Anderson HV, Brindis R, et al. on behalf of the ACC-NCDR. Predictors of outcome of primary PCI in ST segment elevation myocardial infarction in 6521 consecutive cases during 2001: A report from the American College of Cardiology-National Cardiovascular Data Registry. Circulation 2002;106:II-363.
59. Guagliumi G, Stone GW, Cox DA, et al. Outcome in elderly patients undergoing primary coronary intervention for acute myocardial infarction: Results from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. Circulation 2004;110:1598-1604.
60. Halkin A, Stone GW, Grines CG, et al. Outcomes of patients consented but not randomized in a trial of primary percutaneous coronary intervention in acute myocardial infarction (the CADILLAC Registry). Am J Cardiol 2005;96:1649-1652.
61. Montalescot G, Barragan P, Wittenberg D, et al. for the Admiral Investigation. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. N Engl J Med 2001;34:1895-1903.
62. Antoniucci D, Rodriguez A, Hempel A, et al. A randomized trial comparing primary infarct artery stenting with or without abciximab in acute myocardial infarction. J Am Coll Cardiol 2003;42:1879-1885.
63. Abbas AE, Brodie B, Dixon S, et al. Incidence and prognostic impact of gastrointestinal bleeding after percutaneous coronary intervention for acute myocardial infarction. Am J Cardiol 2005;96:173-176.
64. Moriel M, Behar S, Tzivoni D, et al. Management and outcomes of elderly women and men with acute coronary syndromes in 2000 and 2002. Ann Int Med 2005;165:1521-1526.
65. Hochman JS, Sleeper LA, Webb JG, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock? N Engl J Med 1999;341:625-634.
66. Dzavik V, Sleeper LA, Picard MH, et al. Outcomes of patients aged ≥ 75 years in the SHould we emergently revascularize Occluded coronary arteries in Cardiogenic shocK (SHOCK) Trial: Do elderly patients with acute myocardial infarction complicated by cardiogenic shock respond differently to emergent revascularization? Am Heart J 2005;149:1128-1134.
67. Dauerman HL, Goldberg RJ, Malinski M, et al. Outcomes and early revascularization for patients greater than or equal to 65 years of age with cardiogenic shock. Am J Cardiol 2001;87:844-848.
68. Dauerman HL, Ryan TJ Jr, Piper WD, et al. Outcomes of percutaneous coronary intervention among elderly patients in cardiogenic shock: A multicenter, decade-long experience. J Invasive Cardiol 2003;15:380-384.
69. Berger AK, Radford MJ, Krumholz HM. Cardiogenic shock complicating acute myocardial infarction in elderly patients: Does admission to a tertiary center improve survival? Am Heart J 2002;143:768-776.
70. Antoniucci D, Valenti R, Santoro GM, et al. Systematic primary angioplasty in octogenarian and older patients. Am Heart J 1999;138(4 Pt 1):670-674.
71. Prasad A, Lennon RJ, Rihal CS, et al. Outcomes of elderly patients with cardiogenic shock treated with early percutaneous revascularization. Am Heart J 2004;147:1066-1070.
72. Ferguson JD, Orr WP, McKenna CJ, et al. Percutaneous coronary intervention in octogenarian with refractory angina. Heart 2002;88:85-86.
73. Stone PH, Thompson B, Anderson HV, et al. Influence of race, sex, and age on management of unstable angina and non-Q-wave myocardial infarction: The TIMI III registry. JAMA 1996;275:1104-1112.
74. Bach RG, Cannon CP, Weintraub WS, et al. The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromes. Ann Intern Med 2004;141:186-195.
75. Cannon CP, Weintraub, WS, Demopoulos LA, et al. for the TACTICS - Thrombolysis in Myocardial Infarction 18 Investigators. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001:344:1879-1887.
76. The TIME Investigators. Trial of invasive medical therapy in elderly patients with chronic symptomatic coronary-artery disease (TIME): A randomized trial. Lancet 2001;358:951-957.
77. Pfisterer M, Buser P, Osswald S, et al. for the TIME Investigators. Outcome of elderly patients with chronic symptomatic coronary artery disease with an invasive vs. optimal medical treatment strategy. One of results of the randomized TIME Trial. JAMA 2003;289:1117-1123.
78. Pfisterer M, for the TIME Investigators. Long-term care in elderly patients with clinical angina managed therapy by optimal medical therapy. Circulation 2004;110:1213-1218.